Active Ingredient: CLOFAZIMINE
Proprietary Name: LAMPRENE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019500
Product Number: 002
Approval Date: Dec 15, 1986
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information
